Pharma reaches out for ghostwriter

Earlier this week, The Scientist linkurl:reported;http://www.the-scientist.com/news/home/53869/ on a trial comparing the efficacy of a hypertension drug, nebivolol, in African American and white American patients. It seems that Forest Laboratories, the drug's manufacturer, is making all kinds of comparisons for marketing purposes, and resorting to some questionable practices to do so. The Wall Street Journal Health Blog linkurl:reports;http://blogs.wsj.com/health/2007/11/21/odd-ghostwriting-off

By | November 21, 2007

Earlier this week, The Scientist linkurl:reported;http://www.the-scientist.com/news/home/53869/ on a trial comparing the efficacy of a hypertension drug, nebivolol, in African American and white American patients. It seems that Forest Laboratories, the drug's manufacturer, is making all kinds of comparisons for marketing purposes, and resorting to some questionable practices to do so. The Wall Street Journal Health Blog linkurl:reports;http://blogs.wsj.com/health/2007/11/21/odd-ghostwriting-offer-raises-researchers-blood-pressure/ today that earlier this month, the company asked Jean E. Sealey of Weill Cornell Medical College, a well-known expert in hypertension, to author an abstract for an upcoming meeting comparing the drug's effects in men and women. The abstract would be due the following week, but the company said it would provide "editorial support" to smooth the process. When Sealey, who was not involved in conducting the study, asked in a follow-up phone call whether she'd have access to the raw data, the call was cut off. (Forest's science writer for nebivolol, who placed the call to Sealey, told the Health Blog that the cut-off was unintentional.) A Forest spokesperson told the Health Blog that since the abstract would analyze data from already published studies, the company's offer met international medical journal guidelines. However, the company seems to have called off the plan.

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Gut Feeling
    Daily News Gut Feeling

    Sensory cells of the mouse intestine let the brain know if certain compounds are present by speaking directly to gut neurons via serotonin.

  3. Athletes’ Microbiomes Differ from Nonathletes
  4. Government Nixes Teaching Evolution in Turkish Schools
AAAS